adarx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Allow: / Disallow: /admin Disallow: /dev Disallow: /old-site Disallow:
Meta Tags
Title Messenger RNA Targeting | ADARx
Description ADARx is a genetic medicine company focusing on the editing of Messenger RNA Targeting transcripts and oligonucleotide-based
Keywords N/A
Server Information
WebSite adarx faviconadarx.com
Host IP 160.153.46.197
Location United States
Related Websites
Site Rank
More to Explore
adarx.com Valuation
US$7,863,209
Last updated: 2023-05-16 01:22:02

adarx.com has Semrush global rank of 1,346,054. adarx.com has an estimated worth of US$ 7,863,209, based on its estimated Ads revenue. adarx.com receives approximately 907,294 unique visitors each day. Its web server is located in United States, with IP address 160.153.46.197. According to SiteAdvisor, adarx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$7,863,209
Daily Ads Revenue US$7,259
Monthly Ads Revenue US$217,751
Yearly Ads Revenue US$2,613,005
Daily Unique Visitors 60,487
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
adarx.com. A 10798 IP: 160.153.46.197
adarx.com. NS 3600 NS Record: ns63.domaincontrol.com.
adarx.com. NS 3600 NS Record: ns64.domaincontrol.com.
adarx.com. MX 3600 MX Record: 32767 ms76521868.msv1.invalid.
adarx.com. MX 3600 MX Record: 0 adarx-com.mail.protection.outlook.com.
adarx.com. TXT 3600 TXT Record: v=spf1 ip4:12.0.138.220 include:spf.protection.outlook.com -all
adarx.com. TXT 3600 TXT Record: MS=ms76521868
HtmlToTextCheckTime:2023-05-16 01:22:02
Home Our Technology News Join the Team Investors About Contact Home Our Technology News Join the Team Investors About Contact Messenger RNA Targeting for creating life-saving therapeutics Learn More Learn More Learn More Learn More OUR MISSION Our mission is to turn cutting-edge science into life-saving therapeutics To achieve our mission, we are committed to building an innovative, values-driven organization focused on our people, the advancement of our efficient drug platform and the creation of a deep pipeline of therapeutics to address intractable diseases. Passionate Innovators Laser focused on our mission Multi-faceted RNA targeting platform Opportunity for wide ranging therapeutic intervention Research Focus The Platform and Disease Areas The Platform that ADARx is developing ADARx is developing a modality agnostic RNA targeting platform, including oligonucleotides for inhibition, degradation and editing, together with novel oligonucleotide delivery technologies. Disease areas
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 16 Jan 2022 11:36:57 GMT
Server: Apache
X-Powered-By: PHP/7.2.34
Vary: Accept-Encoding,Cookie
X-Redirect-By: WordPress
Upgrade: h2,h2c
Connection: Upgrade
Location: https://www.adarx.com/
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
x-powered-by: PHP/7.2.34
vary: Accept-Encoding,Cookie
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-type: text/html; charset=UTF-8
date: Sun, 16 Jan 2022 11:36:58 GMT
server: Apache
adarx.com Whois Information
Domain Name: ADARX.COM
Registry Domain ID: 2035280376_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-06-14T12:58:25Z
Creation Date: 2016-06-13T18:11:54Z
Registry Expiry Date: 2022-06-13T18:11:54Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS63.DOMAINCONTROL.COM
Name Server: NS64.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-16T08:11:40Z <<<